{"id":67127,"date":"2026-06-02T20:09:06","date_gmt":"2026-06-02T12:09:06","guid":{"rendered":"https:\/\/flcube.com\/?p=67127"},"modified":"2026-06-02T20:09:07","modified_gmt":"2026-06-02T12:09:07","slug":"chinas-nmpa-introduces-comprehensive-medical-device-classification-reforms-with-2-5-year-transitional-periods","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=67127","title":{"rendered":"China&#8217;s NMPA Introduces Comprehensive Medical Device Classification Reforms with 2-5 Year Transitional Periods"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">China&#8217;s <strong>National Medical Products Administration (NMPA)<\/strong> released two landmark regulatory announcements this week: the <strong>&#8220;Announcement on Work Related to the Classification Adjustment of Medical Devices (2026 No. 52)&#8221;<\/strong> and the <strong>&#8220;Announcement on the Working Procedure for Dynamic Adjustment of the Medical Device Classification List (2026 No. 53)&#8221;<\/strong>, establishing a comprehensive framework for medical device classification adjustments with clearly defined transitional periods.<\/p>\n\n\n\n<h2 id=\"h-regulatory-framework-amp-key-provisions\" class=\"wp-block-heading\">Regulatory Framework &amp; Key Provisions<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Issuing Authority<\/strong><\/td><td>National Medical Products Administration (NMPA)<\/td><\/tr><tr><td><strong>Primary Announcements<\/strong><\/td><td>2026 No. 52 (Classification Adjustment) + 2026 No. 53 (Working Procedure)<\/td><\/tr><tr><td><strong>Scope<\/strong><\/td><td>Overall adjustment of specific medical devices or product categories<\/td><\/tr><tr><td><strong>Legal Basis Expansion<\/strong><\/td><td>Incorporates Classification Rules for In Vitro Diagnostic Reagents and Registration\/Filing Measures<\/td><\/tr><tr><td><strong>Applicable Catalogs<\/strong><\/td><td>Medical Device Classification Catalog, Class I Medical Device Products Catalog, IVD Reagents Classification Catalog<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-transitional-period-framework-article-10-guidelines\" class=\"wp-block-heading\">Transitional Period Framework \u2013 Article 10 Guidelines<\/h2>\n\n\n\n<h3 id=\"h-standard-transitional-periods\" class=\"wp-block-heading\">Standard Transitional Periods<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Adjustment Scenario<\/th><th>Transitional Period<\/th><th>Clinical Trial Requirement<\/th><\/tr><\/thead><tbody><tr><td><strong>Non-device \u2192 Class II\/III Device<\/strong><\/td><td><strong>2-3 years<\/strong><\/td><td>2 years (no trials), 3 years (with trials)<\/td><\/tr><tr><td><strong>Lower Class \u2192 Higher Class<\/strong><\/td><td><strong>2-3 years<\/strong><\/td><td>2 years (no trials), 3 years (with trials)<\/td><\/tr><tr><td><strong>Special Circumstances<\/strong><\/td><td><strong>Up to 5 years maximum<\/strong><\/td><td>Case-by-case determination<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 id=\"h-key-principles\" class=\"wp-block-heading\">Key Principles<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Risk-Based Approach<\/strong>: Transitional periods determined by comprehensive assessment of product risks, industrial development status, clinical needs, and stakeholder input<\/li>\n\n\n\n<li><strong>Public Disclosure<\/strong>: All classification adjustments will be publicly announced through official NMPA channels<\/li>\n\n\n\n<li><strong>Primary Obligations<\/strong>: Clear delineation of responsibilities for registrants, filers, and manufacturers in compliance implementation<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-industry-impact-amp-strategic-implications\" class=\"wp-block-heading\">Industry Impact &amp; Strategic Implications<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Aspect<\/th><th>Analysis<\/th><\/tr><\/thead><tbody><tr><td><strong>Regulatory Certainty<\/strong><\/td><td>Predictable 2-5 year timelines enable strategic planning for affected companies<\/td><\/tr><tr><td><strong>IVD Sector Impact<\/strong><\/td><td>Expanded scope specifically includes in vitro diagnostic reagents, affecting significant market segment<\/td><\/tr><tr><td><strong>Compliance Investment<\/strong><\/td><td>Companies must assess portfolio impact and allocate resources for potential reclassification requirements<\/td><\/tr><tr><td><strong>Market Access Strategy<\/strong><\/td><td>Transitional periods provide window for clinical trial completion and regulatory dossier preparation<\/td><\/tr><tr><td><strong>Competitive Dynamics<\/strong><\/td><td>Early movers may gain advantage by proactively addressing potential classification changes<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-implementation-timeline-amp-stakeholder-responsibilities\" class=\"wp-block-heading\">Implementation Timeline &amp; Stakeholder Responsibilities<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Immediate Effect<\/strong>: Announcements effective upon publication<\/li>\n\n\n\n<li><strong>Manufacturer Obligations<\/strong>: Registrants and filers must monitor classification changes and implement compliance measures within specified transitional periods<\/li>\n\n\n\n<li><strong>Clinical Trial Planning<\/strong>: Companies with products requiring clinical evidence should initiate trial planning immediately upon classification announcement<\/li>\n\n\n\n<li><strong>Documentation Updates<\/strong>: Technical files, quality management systems, and labeling may require updates to meet new classification requirements<\/li>\n\n\n\n<li><strong>Stakeholder Engagement<\/strong>: NMPA encourages industry consultation during classification review processes<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The new framework represents a significant maturation of China&#8217;s medical device regulatory system, aligning with international best practices while providing practical implementation timelines that balance patient safety with industry feasibility.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding regulatory implementation and industry compliance. Actual outcomes may differ based on specific NMPA determinations and individual company circumstances.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China&#8217;s National Medical Products Administration (NMPA) released two landmark regulatory announcements this week: the &#8220;Announcement&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[14],"class_list":["post-67127","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-nmpa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China&#039;s NMPA Introduces Comprehensive Medical Device Classification Reforms with 2-5 Year Transitional Periods - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China&#039;s National Medical Products Administration (NMPA) released two landmark regulatory announcements this week: the &quot;Announcement on Work Related to the Classification Adjustment of Medical Devices (2026 No. 52)&quot; and the &quot;Announcement on the Working Procedure for Dynamic Adjustment of the Medical Device Classification List (2026 No. 53)&quot;, establishing a comprehensive framework for medical device classification adjustments with clearly defined transitional periods.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=67127\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China&#039;s NMPA Introduces Comprehensive Medical Device Classification Reforms with 2-5 Year Transitional Periods\" \/>\n<meta property=\"og:description\" content=\"China&#039;s National Medical Products Administration (NMPA) released two landmark regulatory announcements this week: the &quot;Announcement on Work Related to the Classification Adjustment of Medical Devices (2026 No. 52)&quot; and the &quot;Announcement on the Working Procedure for Dynamic Adjustment of the Medical Device Classification List (2026 No. 53)&quot;, establishing a comprehensive framework for medical device classification adjustments with clearly defined transitional periods.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=67127\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-02T12:09:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-02T12:09:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67127#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67127\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China&#8217;s NMPA Introduces Comprehensive Medical Device Classification Reforms with 2-5 Year Transitional Periods\",\"datePublished\":\"2026-06-02T12:09:06+00:00\",\"dateModified\":\"2026-06-02T12:09:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67127\"},\"wordCount\":441,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"NMPA\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67127#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67127\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=67127\",\"name\":\"China's NMPA Introduces Comprehensive Medical Device Classification Reforms with 2-5 Year Transitional Periods - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-06-02T12:09:06+00:00\",\"dateModified\":\"2026-06-02T12:09:07+00:00\",\"description\":\"China's National Medical Products Administration (NMPA) released two landmark regulatory announcements this week: the \\\"Announcement on Work Related to the Classification Adjustment of Medical Devices (2026 No. 52)\\\" and the \\\"Announcement on the Working Procedure for Dynamic Adjustment of the Medical Device Classification List (2026 No. 53)\\\", establishing a comprehensive framework for medical device classification adjustments with clearly defined transitional periods.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67127#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67127\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67127#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China&#8217;s NMPA Introduces Comprehensive Medical Device Classification Reforms with 2-5 Year Transitional Periods\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China's NMPA Introduces Comprehensive Medical Device Classification Reforms with 2-5 Year Transitional Periods - Insight, China&#039;s Pharmaceutical Industry","description":"China's National Medical Products Administration (NMPA) released two landmark regulatory announcements this week: the \"Announcement on Work Related to the Classification Adjustment of Medical Devices (2026 No. 52)\" and the \"Announcement on the Working Procedure for Dynamic Adjustment of the Medical Device Classification List (2026 No. 53)\", establishing a comprehensive framework for medical device classification adjustments with clearly defined transitional periods.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=67127","og_locale":"en_US","og_type":"article","og_title":"China's NMPA Introduces Comprehensive Medical Device Classification Reforms with 2-5 Year Transitional Periods","og_description":"China's National Medical Products Administration (NMPA) released two landmark regulatory announcements this week: the \"Announcement on Work Related to the Classification Adjustment of Medical Devices (2026 No. 52)\" and the \"Announcement on the Working Procedure for Dynamic Adjustment of the Medical Device Classification List (2026 No. 53)\", establishing a comprehensive framework for medical device classification adjustments with clearly defined transitional periods.","og_url":"https:\/\/flcube.com\/?p=67127","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-06-02T12:09:06+00:00","article_modified_time":"2026-06-02T12:09:07+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=67127#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=67127"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China&#8217;s NMPA Introduces Comprehensive Medical Device Classification Reforms with 2-5 Year Transitional Periods","datePublished":"2026-06-02T12:09:06+00:00","dateModified":"2026-06-02T12:09:07+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=67127"},"wordCount":441,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["NMPA"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=67127#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=67127","url":"https:\/\/flcube.com\/?p=67127","name":"China's NMPA Introduces Comprehensive Medical Device Classification Reforms with 2-5 Year Transitional Periods - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-06-02T12:09:06+00:00","dateModified":"2026-06-02T12:09:07+00:00","description":"China's National Medical Products Administration (NMPA) released two landmark regulatory announcements this week: the \"Announcement on Work Related to the Classification Adjustment of Medical Devices (2026 No. 52)\" and the \"Announcement on the Working Procedure for Dynamic Adjustment of the Medical Device Classification List (2026 No. 53)\", establishing a comprehensive framework for medical device classification adjustments with clearly defined transitional periods.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=67127#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=67127"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=67127#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China&#8217;s NMPA Introduces Comprehensive Medical Device Classification Reforms with 2-5 Year Transitional Periods"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=67127"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67127\/revisions"}],"predecessor-version":[{"id":67128,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67127\/revisions\/67128"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=67127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=67127"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=67127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}